Back to trial details

Intake questionnaire

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Applying to Bioresearch Partner · Hialeah, Florida

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Non-squamous Non-small-cell Lung Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Hialeah for study visits?